Genesee Capital Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Buy |
2,365
+11
| +0.5% | +$1.98K | 0.19% | 82 |
|
|
2025
Q1 | $398K | Buy |
2,354
+11
| +0.5% | +$1.86K | 0.2% | 86 |
|
|
2024
Q4 | $353K | Buy |
2,343
+11
| +0.5% | +$1.66K | 0.16% | 93 |
|
|
2024
Q3 | $362K | Buy |
2,332
+12
| +0.5% | +$1.86K | 0.17% | 88 |
|
|
2024
Q2 | $318K | Buy |
2,320
+13
| +0.6% | +$1.78K | 0.16% | 90 |
|
|
2024
Q1 | $307K | Buy |
2,307
+12
| +0.5% | +$1.6K | 0.17% | 87 |
|
|
2023
Q4 | $316K | Buy |
2,295
+14
| +0.6% | +$1.93K | 0.2% | 78 |
|
|
2023
Q3 | $278K | Buy |
2,281
+11
| +0.5% | +$1.34K | 0.2% | 77 |
|
|
2023
Q2 | $319K | Buy |
2,270
+11
| +0.5% | +$1.55K | 0.22% | 68 |
|
|
2023
Q1 | $320K | Buy |
2,259
+10
| +0.4% | +$1.42K | 0.23% | 65 |
|
|
2022
Q4 | $352K | Buy |
2,249
+48
| +2% | +$7.51K | 0.26% | 62 |
|
|
2022
Q3 | $270K | Buy |
2,201
+11
| +0.5% | +$1.35K | 0.21% | 71 |
|
|
2022
Q2 | $291K | Buy |
2,190
+10
| +0.5% | +$1.33K | 0.2% | 76 |
|
|
2022
Q1 | $298K | Buy |
2,180
+9
| +0.4% | +$1.23K | 0.16% | 87 |
|
|
2021
Q4 | $376K | Buy |
2,171
+10
| +0.5% | +$1.73K | 0.18% | 79 |
|
|
2021
Q3 | $314K | Buy |
+2,161
| New | +$314K | 0.15% | 86 |
|
|
2021
Q2 | – | Sell |
-2,141
| Closed | -$275K | – | 66 |
|
|
2021
Q1 | $275K | Buy |
2,141
+9
| +0.4% | +$1.16K | 0.16% | 76 |
|
|
2020
Q4 | $254K | Buy |
2,132
+10
| +0.5% | +$1.19K | 0.17% | 72 |
|
|
2020
Q3 | $242K | Buy |
2,122
+9
| +0.4% | +$1.03K | 0.2% | 67 |
|
|
2020
Q2 | $240K | Buy |
+2,113
| New | +$240K | 0.22% | 64 |
|
|
2020
Q1 | – | Sell |
-2,091
| Closed | -$223K | – | 78 |
|
|
2019
Q4 | $223K | Buy |
2,091
+10
| +0.5% | +$1.07K | 0.19% | 63 |
|
|
2019
Q3 | $222K | Buy |
2,081
+11
| +0.5% | +$1.17K | 0.21% | 64 |
|
|
2019
Q2 | $210K | Buy |
+2,070
| New | +$210K | 0.21% | 62 |
|